Shopping Cart
- Remove All
- Your shopping cart is currently empty
Epratuzumab (Antibody hLL 2), an anti-CD22 IgG1 monoclonal antibody, serves as both a tumor-imaging and immunomodulatory agent. It induces CD22 phosphorylation and has been employed in researching Non-Hodgkin's Lymphomas (NHL) and select autoimmune diseases [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $213 | In Stock | |
5 mg | $558 | In Stock | |
10 mg | $893 | In Stock | |
25 mg | $1,320 | In Stock | |
50 mg | $1,780 | In Stock |
Description | Epratuzumab (Antibody hLL 2), an anti-CD22 IgG1 monoclonal antibody, serves as both a tumor-imaging and immunomodulatory agent. It induces CD22 phosphorylation and has been employed in researching Non-Hodgkin's Lymphomas (NHL) and select autoimmune diseases [1]. |
Cas No. | 205923-57-5 |
Storage | store at low temperature | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.